TTM-020

N/A

Report date: 2025/01/26 16:55:05
NME

Base Information

Drug NameTTM-020
Drug Alias Namemicroglial-targeted glutaminase inhibitor (Johns Hopkins University/Czech Academy of Sciences)TTM-020 analogsTTM-020
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlutaminase inhibitors
TargetsGlutaminase
Therapy Area/IndicationsDepressive Disorder, Major
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesJohns Hopkins University
China Registration ClassN/A

Develop Information

Active CompaniesCzech Academy of SciencesJohns Hopkins University
Inactive CompaniesN/A
Active IndicationsDepressive Disorder, Major
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A